World-first blood cancer therapy to be given on NHS
Summary
A new cancer treatment called "Trojan horse" therapy is now available on the NHS in England for blood cancer known as myeloma. This treatment targets cancer cells directly, slows down the disease more effectively than previous methods, and has fewer side effects, although it can still cause some issues like dry eyes.Key Facts
- The "Trojan horse" therapy is a new treatment for the blood cancer myeloma.
- It is available on the NHS in England and aims to treat patients when other therapies fail.
- The therapy works by delivering toxic drugs directly inside cancer cells.
- It is known as belantamab mafodotin, which combines chemotherapy with antibodies.
- This approach stops cancer for up to three years, compared to 13 months with older treatments.
- Around 1,500 patients could benefit from this therapy each year in the UK.
- The drug is considered cost-effective by NICE for NHS use.
- Possible side effects include dry eyes and blurred vision.
- The drug infusion takes about 30 minutes and is typically given every two months.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.
